Open AccessPlatelet-rich Plasma or Autologous Blood Do Not Reduce Pain or Improve Function in Patients with Lateral Epicondylitis: A Randomized Controlled Trial
Author(s) -
Lasse Linnanmäki,
Kari Kanto,
Teemu Karjalainen,
Olli V. Leppänen,
Janne Lehtinen
Publication year - 2020
Publication title -
clinical orthopaedics and related research
Language(s) - English
Resource type - Journals
eISSN - 1528-1132
pISSN - 0009-921X
DOI - 10.1097/corr.0000000000001185
Subject(s) - epicondylitis , medicine , tennis elbow , randomized controlled trial , platelet rich plasma , grip strength , surgery , placebo , physical therapy , anesthesia , elbow , platelet , alternative medicine , pathology
Platelet-rich plasma (PRP) and autologous blood are commonly used therapies for lateral epicondylitis, but the evidence from randomized, placebo-controlled trials is conflicting. Thus, it is still unclear if patients benefit from these treatments.